Humoral and cellular immunity in secondary infection due to murine Chlamydia trachomatis

A murine model of pneumonia due to the mouse pneumonitis agent (MoPn [murine Chlamydia trachomatis]) in mice deficient in CD4+ T-cell function (major histocompatibility complex [MHC] class II function [class II-/-], CD8+ T-cell function (beta2-microglobulin deficient, MHC class I deficient [Beta2m-/-]), B-cell function (C57BL/10J-Igh(tm1Cgn) [Igh-/-]), and gamma interferon (IFN-gamma) (C57BL/6-Ifg(tm1) [Ifg-/-]) or interleukin-4 (C57BL/6J(tm1Cgn29) [IL4-/-]) production was employed to determine if each of these mechanisms was critical to resistance against reinfection by C. trachomatis or if alternate compensatory mechanisms existed in their absence which could potentially be exploited in vaccine development. Resistance to reinfection with MoPn was heavily dependent on CD4+ T cells. CD4 T-cell-deficient MHC class II-/- mice were very susceptible to reinfection with MoPn, showing the critical importance of this cell to resistance. These mice lacked antibody production but did produce IFN-gamma, apparently by mechanisms involving NK and CD8+ T cells. Neutralization of IFN-gamma in these mice led to a borderline increase in susceptibility, showing a possible role (albeit small) of this cytokine in this setting. Tumor necrosis factor alpha (TNF-alpha) was also present at increased levels in these mice. Igh-/- B-cell-deficient mice which produce no antibody to MoPn were only modestly more susceptible to reinfection than immunized B-cell-intact controls, showing that antibody, including lung immunoglobulin A, is not an absolute requirement for relatively successful host defense in this setting. Levels of lung IFN-gamma and TNF-alpha were elevated in Igh-/- mice compared to those in controls. IL-4-/- mice (deficient in Th2 function) could develop normal resistance to reinfection with MoPn. Conversely, normal mice rendered partially IFN-gamma deficient by antibody depletion were somewhat impaired in their ability to develop acquired immunity to MoPn, again indicating a role for this cytokine in host defense against rechallenge. Of most importance, however, congenitally IFN-gamma-deficient Ifg-/- mice (which have elevated levels of other cytokines, including TNF-alpha and granulocyte-macrophage colony-stimulating factor) are paradoxically more resistant to MoPn rechallenge than controls, showing that IFN-gamma is not an absolute requirement for acquired resistance and implying the presence of very effective compensatory host defense mechanism(s). In vivo depletion of TNF-alpha significantly increased MoPn levels in the lungs in these mice. Thus, resistance to reinfection in this model is flexible and multifactorial and is heavily dependent on CD4+ T cells, with a probable role for IFN-gamma and TNF-alpha and a possible modest role for Th1-dependent antibody. Since IFN-gamma was dispensable in host defense, the highly effective mechanism or mechanisms which can compensate for its absence (which include TNF-alpha) deserve further study.

[1]  A. George Generation of gamma interferon responses in murine Peyer's patches following oral immunization , 1996, Infection and immunity.

[2]  R. Brunham,et al.  Genetically determined differences in IL-10 and IFN-gamma responses correlate with clearance of Chlamydia trachomatis mouse pneumonitis infection. , 1996, Journal of immunology.

[3]  R. Ahmed,et al.  CD8 T cell memory in B cell-deficient mice , 1996, The Journal of experimental medicine.

[4]  A. Taylor-Robinson,et al.  Reconstitution of B-cell-depleted mice with B cells restores Th2-type immune responses during Plasmodium chabaudi chabaudi infection , 1996, Infection and immunity.

[5]  H. Caldwell,et al.  Protective efficacy of major outer membrane protein-specific immunoglobulin A (IgA) and IgG monoclonal antibodies in a murine model of Chlamydia trachomatis genital tract infection , 1995, Infection and immunity.

[6]  R. Morrison,et al.  Gene knockout mice establish a primary protective role for major histocompatibility complex class II-restricted responses in Chlamydia trachomatis genital tract infection , 1995, Infection and immunity.

[7]  M. Bevan,et al.  Specific immunity to Listeria monocytogenes in the absence of IFN gamma. , 1995, Immunity.

[8]  R. Rank,et al.  Role of CD8 T cells in primary Chlamydia infection , 1995, Infection and immunity.

[9]  M. Starnbach,et al.  Protective cytotoxic T lymphocytes are induced during murine infection with Chlamydia trachomatis. , 1994, Journal of immunology.

[10]  R. Rank,et al.  Role for CD8+ T cells in antichlamydial immunity defined by Chlamydia-specific T-lymphocyte clones , 1994, Infection and immunity.

[11]  J. Langhorne,et al.  The immune response to Plasmodium chabaudi malaria in interleukin‐4‐deficient mice , 1994, European journal of immunology.

[12]  R. Rank,et al.  Chlamydia trachomatis pneumonia in the severe combined immunodeficiency (SCID) mouse. , 1993, Regional immunology.

[13]  R. Rank,et al.  Resolution of murine chlamydial genital infection by the adoptive transfer of a biovar-specific, Th1 lymphocyte clone. , 1993, Regional immunology.

[14]  D. Magee,et al.  Gamma interferon levels during Chlamydia trachomatis pneumonia in mice , 1993, Infection and immunity.

[15]  A. Bradley,et al.  Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. , 1993, Science.

[16]  L. Guilloteau,et al.  Protection against Chlamydia psittaci in mice conferred by Lyt-2+ T cells. , 1992, Immunology.

[17]  R. Rank,et al.  Effect of gamma interferon on resolution of murine chlamydial genital infection , 1992, Infection and immunity.

[18]  K. Rajewsky,et al.  Generation and analysis of interleukin-4 deficient mice. , 1991, Science.

[19]  MJ Grusby,et al.  Depletion of CD4+ T cells in major histocompatibility complex class II-deficient mice , 1991, Science.

[20]  D. Magee,et al.  Production of colony-stimulating factors during pneumonia caused by Chlamydia trachomatis , 1991, Infection and immunity.

[21]  Klaus Rajewsky,et al.  A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin μ chain gene , 1991, Nature.

[22]  L. Bonewald,et al.  A role in vivo for tumor necrosis factor alpha in host defense against Chlamydia trachomatis , 1990, Infection and immunity.

[23]  B. Koller,et al.  Inactivating the beta 2-microglobulin locus in mouse embryonic stem cells by homologous recombination. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[24]  D. Williams,et al.  Role in vivo for gamma interferon in control of pneumonia caused by Chlamydia trachomatis in mice , 1988, Infection and immunity.

[25]  R. Rank,et al.  Resolution of chlamydial genital infection in B-cell-deficient mice and immunity to reinfection , 1988, Infection and immunity.

[26]  D. Williams,et al.  Primary murine Chlamydia trachomatis pneumonia in B-cell-deficient mice , 1987, Infection and immunity.

[27]  D. Williams,et al.  Chlamydia trachomatis pneumonia in the immune, athymic and normal BALB mouse. , 1987, British journal of experimental pathology.

[28]  D. Williams,et al.  Role of natural killer cells in infection with the mouse pneumonitis agent (murine Chlamydia trachomatis) , 1987, Infection and immunity.

[29]  D. Williams,et al.  Antibody in host defense against mouse pneumonitis agent (murine Chlamydia trachomatis) , 1984, Infection and immunity.

[30]  C. Sumaya,et al.  The role of antibody in host defense against the agent of mouse pneumonitis. , 1982, The Journal of infectious diseases.

[31]  C. Sumaya,et al.  Pneumonia due to Chlamydia trachomatis in the immunocompromised (nude) mouse. , 1981, The Journal of infectious diseases.

[32]  P. Ogra Handbook of mucosal immunology , 1994 .